Suppr超能文献

在接受减强度预处理条件后,C 反应蛋白水平可预测异基因干细胞移植后的结果。

C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation.

机构信息

Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

出版信息

Int J Hematol. 2010 Jul;92(1):161-7. doi: 10.1007/s12185-010-0632-7. Epub 2010 Jun 25.

Abstract

The prognostic value of CRP levels before conditioning for allogeneic stem-cell transplantation (ASCT) was evaluated. Reduced-intensity conditioning (RIC) was given to 205 patients and conventional myeloablative conditioning (MAC) to 299 patients. Most patients had an HLA-compatible related or unrelated donor. There were 287 males and 216 females, median age 36 (1-69) years. Most patients received peripheral blood stem cells. Increased CRP levels (>10 mg/L) were detected in 129 patients (26%). Overall survival (OS) and transplant-related mortality (TRM) were worse for RIC patients with elevated CRP (67 vs. 43%, p = 0.005, and 16 vs. 30%, p = 0.036) while no difference was seen in MAC patients. An infection at the start of conditioning was seen in 27 RIC patients. We identified a subgroup of patients with an infection and elevated CRP (n = 16) and these patients had the worst outcome. In multivariate analysis, both infection and elevated CRP was the strongest factor associated with OS (HR 3.27, p < 0.001) and TRM (HR 4.35, p < 0.001). No correlation between any outcome variable and CRP was seen in MAC-treated patients. CRP may be a good prognostic factor for outcome after RIC and ASCT. It should be analyzed before conditioning, especially in patients with coexisting infection since patients with increased CRP and infection seem to have a very poor outcome after ASCT.

摘要

评估了 CRP 水平在异基因干细胞移植(ASCT)预处理前的预后价值。205 例患者接受了低强度预处理(RIC),299 例患者接受了常规清髓性预处理(MAC)。大多数患者有 HLA 相容的亲缘或非亲缘供者。有 287 名男性和 216 名女性,中位年龄为 36(1-69)岁。大多数患者接受了外周血干细胞移植。129 例(26%)患者 CRP 水平升高(>10mg/L)。RIC 患者 CRP 升高(67% vs. 43%,p=0.005)和 TRM(16% vs. 30%,p=0.036)较差,而 MAC 患者无差异。RIC 患者预处理开始时发生感染 27 例。我们确定了一组感染和 CRP 升高的患者(n=16),这些患者的结局最差。多因素分析显示,感染和 CRP 升高均是 OS(HR 3.27,p<0.001)和 TRM(HR 4.35,p<0.001)的最强相关因素。MAC 治疗患者的任何结局变量与 CRP 均无相关性。CRP 可能是 RIC 和 ASCT 后结局的良好预后因素。应在预处理前进行分析,尤其是在伴有合并感染的患者中,因为 CRP 升高合并感染的患者在 ASCT 后似乎预后极差。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验